|
|
Article: /C O R R E C T I O N -- Eon Labs Manufacturing, Inc./.
- Article from:
- PR Newswire
- Article date:
- January 19, 2000
CopyrightCOPYRIGHT 2000 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
In NYTU158, Eon Labs Receives FDA Approval for Generic of the Biggest Selling Immunosuppressive Product, moved yesterday, Jan. 18, the product mentioned in the first graph, third line should read "Neoral(R)," rather than "Neoral?," as incorrectly transmitted by PR Newswire. The complete, corrected release follows:
Eon Labs Receives FDA Approval for Generic of the Biggest Selling
Immunosuppressive Product
LAURELTON, N.Y., Jan. 18 /PRNewswire/ -- Eon Labs Manufacturing, Inc. announced today that the Food and Drug Administration has approved their AB-rated generic equivalent of Novartis Pharmaceuticals' Neoral(R), the biggest selling softgel ...